Journal article

Weekly cholecalciferol supplementation results in significant reductions in infection risk among the vitamin D deficient: Results from the CIPRIS pilot RCT

S Simpson, I Van Der Mei, N Stewart, L Blizzard, P Tettey, B Taylor

BMC Nutrition | Springer Science and Business Media LLC | Published : 2015


Background: Observational studies suggest vitamin D deficiency may contribute to the risk of acute infections. We undertook a randomised controlled trial (RCT) of cholecalciferol supplementation as an intervention against acute infections. Methods: A cohort of 34 healthy adults was randomised to 20,000 IU/week cholecalciferol or identical placebo and followed for 17 weeks during winter 2012. Acute infections, defined as the occurrence of sustained (at least an hour) infection symptoms, either of severity 2/5 or greater or sustained over 24 h, were monitored by daily online symptom reporting, with potential infections assessed in clinic. No microbiological verification of symptoms was availab..

View full abstract


Citation metrics